NextCure, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €547.86K
    Gross profit
    -€547.86K
    SG&A expenses
    €12.29M
    R&D expenses
    €42.98M
    EBITDA
    -€53.52M
    D&A
    €1.19M
    EBIT
    -€55.27M
    Interest expenses
    €0.00
    EBT
    -€52.73M
    Tax expenses
    €0.00
    Net income
    -€52.73M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€3.45M
    Changes in working capital
    €3.04M
    Operating cash flow
    -€46.85M
    Capex
    €117.71K
    Other investing cash flow
    €0.00
    Net investing cash flow
    €31.26M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €1.65M
    Debt repayment
    €0.00
    Other financing cash flow
    €32.02K
    Net financing cash flow
    €1.78M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€13.81M
    Cash at end of period
    €4.23M
    Free cash flow
    -€46.73M

    Balance sheet

    Cash and cash equivalents
    €4.23M
    Cash and short-term investments
    €30.56M
    Total receivables
    €173.10K
    Inventory
    €0.00
    Other current assets
    €3.90M
    Total current assets
    €34.63M
    Property, plant & equipment
    €6.16M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €480.35K
    Total non-current assets
    €6.64M
    Total assets
    €41.27M
    Accounts payable
    €2.20M
    Short-term debt
    €553.06K
    Other current liabilities
    €6.58M
    Total current liabilities
    €9.33M
    Long-term debt
    €4.04M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €515.84K
    Total non-current liabilities
    €4.55M
    Total liabilities
    €13.89M
    Common stock
    €1.73M
    Retained earnings
    -€361.71M
    Other equity
    -€6.06K
    Total equity
    €27.39M
    Total liabilities and shareholders' equity
    €41.27M

    Company information

    Market capitalization
    €27.49M
    Employees
    43
    Enterprise Value
    €342.48K

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -192.5% Much worse than peer group: -105.7%
    ROA
    -127.8% Much worse than peer group: -53.7%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -170.8%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.23M

    Notifications